| abstract |
The present invention relates to a pharmaceutical hemostatic foam base preparation comprising albumin and fibrinogen precipitant as foaming agent and optionally a coagulation inducing agent (wherein albumin as foaming agent exists in natural form) A method for producing a transient hemostatic foam; a transient hemostatic foam; and a kit for producing the foam. In one aspect, the albumin is present as a blowing agent in the preparation in 2-40%, preferably 5-25% w / v, more preferably 10-20%, especially about 15%. . |